E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers O > Headlines for Orchid Chemicals & Pharmaceuticals Ltd. > News item
Published on 2/14/2006 in the Prospect News Biotech Daily.

Orchid receives FDA OK for Cefoxitin

By Lisa Kerner

Erie, Pa., Feb. 14 - Orchid Chemicals & Pharmaceuticals Ltd. said it has received U.S. Food and Drug Administration approval for its Abbreviated New Drug Application for Cefoxitin Injection, 10 g/vial.

Orchid Chemicals & Pharmaceuticals Ltd. is an integrated pharmaceutical major headquartered in Chennai, India, with diversified competencies in bulk drugs, formulations and drug discovery, with a strong orientation towards the advanced regulated markets.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.